Urologie Vaterstetten - Dr. med. Block, Vaterstetten
Urologie Vaterstetten - Dr. med. Block, Vaterstetten
Urologie Vaterstetten - Dr. med. Block, Vaterstetten
Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.
YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.
116. Potters L, TorreT, Fearn P, Leibel S, Kattan M: Potency after permanent prostate<br />
brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 50:1235–1242,<br />
2001<br />
117. Potters L: Permanent prostate brachytherapy: Lessons learned, lessons to learn. Oncology<br />
14:2000<br />
118. Pound CR, Christens-Barry OW, Gurganus RT: Digital rectal examination and imaging<br />
studies are unnecessary in men with undetectable prostate specific antigen following<br />
radical prostatectomy. J Urol 162:1337-1340, 1999<br />
119. Pound CR, Partin AW, Epstein JI, Walsh PC: Prostate-specific antigen after anatomic<br />
radical retropubic prostatectonomy. Urol Clin North Am 24:395–406, 1998<br />
120. Ramos C, Caravalhal G, Smith D, Mager D, Catalona, W: Retrospective comparison of<br />
radical retropubic prostatectomy and 125 Iodine brachytherapy for localized prostate<br />
cancer. J Urol 161,1212–1215, 1999<br />
121. Radge H, Grado G, Nadir B: Brachytherapy for clinically localized prostate cancer: Thirteen<br />
years disease-free survival of 769 consecutive prostate cancer patients treated with<br />
permanent implants alone. Arch Esp Urol 54:739-747, 2001<br />
122. Radge H, Korb L, Elgamal AA, Grado G, Nadir B: Modern prostate brachytherapy. Cancer<br />
89: 135–141, 2000<br />
123. Radge H, Blasko J, Grimm P: Interstitial iodine-125 radiation without adjuvant therapy in<br />
treatment of clinically localized prostate carcinoma Cancer 80:442-453, 1999<br />
124. Roach M, Meehan S, Kroll S, et al. Radiotherapy for high grade clinically localized<br />
adenocarcinoma of the prostate. J Urol 156:1719–1723, 1996<br />
125. Robinson JW, Moritz S, Fung TS: Erectile function of men following brachytherapy<br />
caompared with other treatments for localized prostate carcinoma. Int J Rad Oncol Biol<br />
Phys 48:89-93, 2000<br />
126. Roy JN, Wallner KE, Harrington PJ, Ling CC, Anderson CL: A CT-based evaluation<br />
method for permanent implants: Application to prostate brachytherapy. Int J Radiat Oncol<br />
Biol Phys 26:163-169, 1993<br />
127. Russel K, Caplan R, Lamamore G, Burnison C, Maor M, Taylor M, Zink S, Davis L, Griffin<br />
T: Photon versus fast neutron external beam radiotherapy in the treatment of locally<br />
advanced prostate cancer: results of a randomized prospective trial. Int J Radiat Oncol Biol<br />
Phys 28:47–54, 1993<br />
128. Sánchez-Ortiz R, Broderick G, Wein A, Whittington A, Malkowicz S: Erectile function and<br />
quality of life after interstitial radiation therapy for prostate cancer. Int J Impot Res 12:18–<br />
24, 2000<br />
129. Saw CB, Suntharalingam S. Reference dose rates for single- and double-plane 192 Ir<br />
implants. Med Phys 15:392-396, 1988<br />
130. Saw CB, Suntharalingham N,Ayyangar K: Dosimetric considerations of stereotactic brain<br />
implants. Int J Radiat Oncol Biol Phys 17:887-891, 1989<br />
131. Shanahan TG, Nanavati PJ, Mueller PW, Maxey RB: A comparison of permanent prostate<br />
brachytherapy techniques: Preplan versus hybrid interactive planning with postimplant<br />
analysis. Int J Rad Oncol Biol Phy, 53:490-496, 2002<br />
132. Sharkey J, Cantor A, Solc Z, Huff W, Chovnick SD, Behar RJ, Perez R, Otheguy J,<br />
Rabinowitz R: Brachytherapy versus radical prostatectomy in patients with clinically<br />
localized prostate cancer. Curr Urol Rep 3:250–257, 2002<br />
87